Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2026-01-29 @ 4:28 PM
Study NCT ID:
NCT02966795
Status:
COMPLETED
Last Update Posted:
2021-07-30
First Post:
2016-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatitis C Virus (HCV) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | glecaprevir | View |
| None | pibrentasvir | View |
| None | compensated cirrhosis | View |
| None | non-cirrhotic | View |
| None | interferon (IFN) | View |
| None | pegylated interferon (pegIFN) | View |
| None | ribavirin (RBV) | View |
| None | sofosbuvir (SOF) | View |
| None | Sustained Virologic Response 12 weeks post dosing (SVR12) | View |
| None | Chronic | View |
| None | Genotype 5 or 6 Infection | View |